Durlobactam, a Diazabicyclooctane β‑Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis
Article in ACS Infectious Diseases (April 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in ACS Infectious Diseases (April 2024)
Article in Expert Opinion on Investigational Drugs (March 2024)
Article in European Journal of Clinical Microbiology & Infectious Diseases (February 2024)